AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
THE PHARMACOKINETICS OF BX-807834 (BX), A POTENT, SELECTIVE FACTOR XAINHIBITOR IN ANIMALS
Authors: SUBRAMANYAM B HO E WALTERS J CHEESMAN S GUILFORD W VERGONA R WHITE K PHILLIPS G DAVEY D MORRISSEY M LIGHT D MORSER J SULLIVAN M
Citation: B. Subramanyam et al., THE PHARMACOKINETICS OF BX-807834 (BX), A POTENT, SELECTIVE FACTOR XAINHIBITOR IN ANIMALS, The FASEB journal, 12(5), 1998, pp. 4169-4169
IN-VITRO INHIBITION OF FACTOR XA (XA) AND PROTHROMBINASE (PTASE) BY BX-807834 (BX), A POTENT, SELECTIVE ACTIVE-SITE INHIBITOR
Authors: LIGHT D LIANG A RUMENNIK G CLARKE J MCLEAN K POST J TRINH L PHILLIPS G DAVEY D GUILFORD W MORSER J MORRISSEY M SULLIVAN M
Citation: D. Light et al., IN-VITRO INHIBITION OF FACTOR XA (XA) AND PROTHROMBINASE (PTASE) BY BX-807834 (BX), A POTENT, SELECTIVE ACTIVE-SITE INHIBITOR, The FASEB journal, 12(5), 1998, pp. 4170-4170
THE EFFICACY AND SAFETY OF BX-807834 (BX), A POTENT, SELECTIVE FACTORXA INHIBITOR IN ANIMAL-MODELS
Authors: SULLIVAN M MORSER J LIGHT D GUILFORD W VERGONA R HERRMANN M WHITE K PHILLIPS G DAVEY D MORRISSEY M FREDRICH M BALDUS B
Citation: M. Sullivan et al., THE EFFICACY AND SAFETY OF BX-807834 (BX), A POTENT, SELECTIVE FACTORXA INHIBITOR IN ANIMAL-MODELS, The FASEB journal, 12(5), 1998, pp. 4171-4171
GENERATION AND CHARACTERIZATION OF MICE DEFICIENT IN HEPSIN, A HEPATIC TRANSMEMBRANE SERINE-PROTEASE
Authors: WU QY YU DY POST J HALKSMILLER M SADLER JE MORSER J
Citation: Qy. Wu et al., GENERATION AND CHARACTERIZATION OF MICE DEFICIENT IN HEPSIN, A HEPATIC TRANSMEMBRANE SERINE-PROTEASE, The Journal of clinical investigation, 101(2), 1998, pp. 321-326
BOTH CELLULAR AND SOLUBLE FORMS OF THROMBOMODULIN INHIBIT FIBRINOLYSIS BY POTENTIATING THE ACTIVATION OF THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR
Authors: BAJZAR L NESHEIM M MORSER J TRACY PB
Citation: L. Bajzar et al., BOTH CELLULAR AND SOLUBLE FORMS OF THROMBOMODULIN INHIBIT FIBRINOLYSIS BY POTENTIATING THE ACTIVATION OF THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR, The Journal of biological chemistry, 273(5), 1998, pp. 2792-2798
IDENTIFICATION OF SPECIFIC RESIDUES IN THROMBIN MEDIATING PROTEIN-C AND TAFI ACTIVATION
Authors: HALL SW NAGASHIMA M MORSER J ZHAO L LEUNG LLK
Citation: Sw. Hall et al., IDENTIFICATION OF SPECIFIC RESIDUES IN THROMBIN MEDIATING PROTEIN-C AND TAFI ACTIVATION, Circulation, 98(17), 1998, pp. 197-197
THE INHIBITION OF THROMBIN BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 - EFFECTS OF VARIABLE REGION-1 MUTATIONS AND THROMBOMODULIN
Authors: DEKKER RJ VANMEIJER M STOOP AA MORSER J PANNEKOEK H HORREVOETS AJG
Citation: Rj. Dekker et al., THE INHIBITION OF THROMBIN BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 - EFFECTS OF VARIABLE REGION-1 MUTATIONS AND THROMBOMODULIN, Thrombosis and haemostasis, 1997, pp. 1438-1438
THE STRUCTURAL ELEMENTS OF THROMBOMODULIN ESSENTIAL FOR PROTEIN-C ACTIVATION ARE DIFFERENT FROM THOSE REQUIRED FOR TAFI ACTIVATION
Authors: WANG W NAGASHIMA M MANUEL R MORSER J NESHEIM ME
Citation: W. Wang et al., THE STRUCTURAL ELEMENTS OF THROMBOMODULIN ESSENTIAL FOR PROTEIN-C ACTIVATION ARE DIFFERENT FROM THOSE REQUIRED FOR TAFI ACTIVATION, Thrombosis and haemostasis, 1997, pp. 2243-2243
GENERATION AND CHARACTERIZATION OF MICE DEFICIENT FOR THE SERINE-PROTEASE HEPSIN
Authors: WU QY YU DY POST J SADLER JE MORSER J
Citation: Qy. Wu et al., GENERATION AND CHARACTERIZATION OF MICE DEFICIENT FOR THE SERINE-PROTEASE HEPSIN, Thrombosis and haemostasis, 1997, pp. 3090-3090
THROMBIN, THROMBOMODULIN AND TAFI IN THE MOLECULAR LINK BETWEEN COAGULATION AND FIBRINOLYSIS
Authors: NESHEIM M WANG W BOFFA M NAGASHIMA M MORSER J BAJZAR L
Citation: M. Nesheim et al., THROMBIN, THROMBOMODULIN AND TAFI IN THE MOLECULAR LINK BETWEEN COAGULATION AND FIBRINOLYSIS, Thrombosis and haemostasis, 78(1), 1997, pp. 386-391
RECOMBINANT ADVANCED GLYCATION END-PRODUCT RECEPTOR PHARMACOKINETICS IN NORMAL AND DIABETIC RATS
Authors: RENARD C CHAPPEY O WAUTIER MP NAGASHIMA M LUNDH E MORSER J ZHAO L SCHMIDT AM SCHERRMANN JM WAUTIER JL
Citation: C. Renard et al., RECOMBINANT ADVANCED GLYCATION END-PRODUCT RECEPTOR PHARMACOKINETICS IN NORMAL AND DIABETIC RATS, Molecular pharmacology, 52(1), 1997, pp. 54-62
FUNCTIONAL-CHARACTERIZATION OF RECOMBINANT HUMAN MEIZOTHROMBIN AND MEIZOTHROMBIN(DESF1) - THROMBOMODULIN-DEPENDENT ACTIVATION OF PROTEIN-C AND THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI), PLATELET-AGGREGATION, ANTITHROMBIN-III INHIBITION
Authors: COTE HCF BAJZAR L STEVENS WK SAMIS JA MORSER J MACGILLIVRAY RTA NESHEIM ME
Citation: Hcf. Cote et al., FUNCTIONAL-CHARACTERIZATION OF RECOMBINANT HUMAN MEIZOTHROMBIN AND MEIZOTHROMBIN(DESF1) - THROMBOMODULIN-DEPENDENT ACTIVATION OF PROTEIN-C AND THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI), PLATELET-AGGREGATION, ANTITHROMBIN-III INHIBITION, The Journal of biological chemistry, 272(10), 1997, pp. 6194-6200
HIGH-CAPACITY SCREENING OF POOLED COMPOUNDS - IDENTIFICATION OF THE ACTIVE COMPOUND WITHOUT RE-ASSAY OF POOL MEMBERS
Authors: DEVLIN JJ LIANG A TRINH L POLOKOFF MA SENATOR D ZHENG W KONDRACKI J KRETSCHMER PJ MORSER J LIPSON SE SPANN R LOUGHLIN JA DUNN KV MORRISSEY MM
Citation: Jj. Devlin et al., HIGH-CAPACITY SCREENING OF POOLED COMPOUNDS - IDENTIFICATION OF THE ACTIVE COMPOUND WITHOUT RE-ASSAY OF POOL MEMBERS, Drug development research, 37(2), 1996, pp. 80-85
SOLUBLE THROMBOMODULIN ANTIGEN IN PLASMA IS INCREASED IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY
Authors: OHLIN AK MORSER J OHLIN H
Citation: Ak. Ohlin et al., SOLUBLE THROMBOMODULIN ANTIGEN IN PLASMA IS INCREASED IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY, Thrombosis research, 82(4), 1996, pp. 313-322
RAGE AND AMYLOID-BETA PEPTIDE NEUROTOXICITY IN ALZHEIMERS-DISEASE
Authors: YAN SD CHEN X FU J CHEN M ZHU HJ ROHER A SLATTERY T ZHAO L NAGASHIMA M MORSER J MIGHELI A NAWROTH P STERN D SCHMIDT AM
Citation: Sd. Yan et al., RAGE AND AMYLOID-BETA PEPTIDE NEUROTOXICITY IN ALZHEIMERS-DISEASE, Nature, 382(6593), 1996, pp. 685-691
TAFI, OR PLASMA PROCARBOXYPEPTIDASE-B, COUPLES THE COAGULATION AND FIBRINOLYTIC CASCADES THROUGH THE THROMBIN-THROMBOMODULIN COMPLEX
Authors: BAJZAR L MORSER J NESHEIM M
Citation: L. Bajzar et al., TAFI, OR PLASMA PROCARBOXYPEPTIDASE-B, COUPLES THE COAGULATION AND FIBRINOLYTIC CASCADES THROUGH THE THROMBIN-THROMBOMODULIN COMPLEX, The Journal of biological chemistry, 271(28), 1996, pp. 16603-16608
THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE) IS A CELL-SURFACE RECEPTOR FOR AMPHOTERIN IN THE DEVELOPING CENTRAL-NERVOUS-SYSTEM (CNS) TO PROMOTE NEURITE OUTGROWTH
Authors: HORI O CAO R BRETT J SLATTERY T NAGASHIMA M NITECKI D MORSER J STERN D SCHMIDT AM
Citation: O. Hori et al., THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE) IS A CELL-SURFACE RECEPTOR FOR AMPHOTERIN IN THE DEVELOPING CENTRAL-NERVOUS-SYSTEM (CNS) TO PROMOTE NEURITE OUTGROWTH, The FASEB journal, 9(3), 1995, pp. 382-382
SOLUBLE PLASMA THROMBOMODULIN IS INCREASED IN AMI-PATIENTS TREATED WITH THROMBOLYTIC THERAPY
Authors: OHLIN AK MORSER J OHLIN HE
Citation: Ak. Ohlin et al., SOLUBLE PLASMA THROMBOMODULIN IS INCREASED IN AMI-PATIENTS TREATED WITH THROMBOLYTIC THERAPY, Thrombosis and haemostasis, 73(6), 1995, pp. 1327-1327
THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE) IS A CELLULAR-BINDING SITE FOR AMPHOTERIN - MEDIATION OF NEURITE OUTGROWTH AND COEXPRESSION OF RAGE AND AMPHOTERIN IN THE DEVELOPING NERVOUS-SYSTEM
Authors: HORI O BRETT J SLATTERY T CAO R ZHANG JH CHEN JX NAGASHIMA M LUNDH ER VIJAY S NITECKI D MORSER J STERN D SCHMIDT AM
Citation: O. Hori et al., THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE) IS A CELLULAR-BINDING SITE FOR AMPHOTERIN - MEDIATION OF NEURITE OUTGROWTH AND COEXPRESSION OF RAGE AND AMPHOTERIN IN THE DEVELOPING NERVOUS-SYSTEM, The Journal of biological chemistry, 270(43), 1995, pp. 25752-25761
THE STRUCTURE OF A 19-RESIDUE FRAGMENT FROM THE C-LOOP OF THE 4TH EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF THROMBOMODULIN
Authors: ADLER M SETO MH NITECKI DE LIN JH LIGHT DR MORSER J
Citation: M. Adler et al., THE STRUCTURE OF A 19-RESIDUE FRAGMENT FROM THE C-LOOP OF THE 4TH EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF THROMBOMODULIN, The Journal of biological chemistry, 270(40), 1995, pp. 23366-23372
A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS
Authors: PRAUS M MO XM GROSSE Y BALDUS B MORSER J DECHEND R GULBA DC
Citation: M. Praus et al., A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS, Circulation, 92(8), 1995, pp. 2989-2989
RECEPTOR-DEPENDENT HYPERFIBRINOGENEMIA IN DIABETIC MICE - REVERSAL BYBLOCKADE OF THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS
Authors: SCHMIDT AM HORI O ZHANG J CAO R YAN SD NAGASHIMA M FUENTES NL FULLER G MORSER J STERN D
Citation: Am. Schmidt et al., RECEPTOR-DEPENDENT HYPERFIBRINOGENEMIA IN DIABETIC MICE - REVERSAL BYBLOCKADE OF THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS, Circulation, 92(8), 1995, pp. 3333-3333
FUNCTIONAL-PROPERTIES OF RECOMBINANT HUMAN MEIZOTHROMBIN AND MEIZOTHROMBINDESF1
Authors: COTE HCF BAJZAR L STEVENS WK SAMIS JA MORSER J NESHEIM ME MACGILLIVRAY RTA
Citation: Hcf. Cote et al., FUNCTIONAL-PROPERTIES OF RECOMBINANT HUMAN MEIZOTHROMBIN AND MEIZOTHROMBINDESF1, Blood, 86(10), 1995, pp. 274-274
A NEW ANIMAL-MODEL OF VENOUS THROMBOSIS IN RATS WITH LOW-FLOW CONDITIONS IN THE VENOUS-BLOOD STREAM
Authors: FREDRICH M ZIERZ R MORSER J WYDRO R WITT W
Citation: M. Fredrich et al., A NEW ANIMAL-MODEL OF VENOUS THROMBOSIS IN RATS WITH LOW-FLOW CONDITIONS IN THE VENOUS-BLOOD STREAM, Blood coagulation & fibrinolysis, 5(2), 1994, pp. 243-248
EXPRESSION EFFICIENCY OF THE HUMAN THROMBOMODULIN-ENCODING GENE IN VARIOUS VECTOR AND HOST SYSTEMS
Authors: LIN JH WANG MP ANDREWS WH WYDRO R MORSER J
Citation: Jh. Lin et al., EXPRESSION EFFICIENCY OF THE HUMAN THROMBOMODULIN-ENCODING GENE IN VARIOUS VECTOR AND HOST SYSTEMS, Gene, 147(2), 1994, pp. 287-292
Risultati: 1-25 | 26-32